| Financial Year |
March 31 2023 |
| Monetary Funds |
389,327,495.26 |
| Held-for-trading Financial Assets |
1,142,226,623.97 |
| Notes Receivable |
263,554.70 |
| Accounts Receivable |
477,644,528.94 |
| Advances to Suppliers |
9,523,369.00 |
| Other Receivables |
43,078,835.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
302,438,460.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,244,520.55 |
| Other Current Assets |
544,626.15 |
| Total Current Assets |
2,423,166,068.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
100,440,501.10 |
| Investment Properties |
70,058,259.58 |
| Fixed Assetes |
326,889,649.68 |
| Under-construction Projects |
155,316,641.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,114,066.79 |
| R&D expenses |
-- |
| Goodwill |
55,065,115.21 |
| Long-Term Deferred and Prepaid Expenses |
2,064,324.66 |
| Deferred Income Tax Assets |
25,928,179.34 |
| Other Non-Current Assets |
104,944,266.85 |
| Sub-Total of Non-Current Assets |
984,140,440.28 |
| Total Assets |
3,407,306,508.70 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,622,513.70 |
| Accounts Payable |
302,626,057.22 |
| Accounts Received In Advance |
919,508.38 |
| Employee Compensation Payable |
24,709,699.80 |
| Taxes Payable |
17,283,370.39 |
| Interest Payable |
-- |
| Dividend Payable |
84,490.00 |
| Other payables |
42,532,945.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
4,963,312.56 |
| Sub-Total of Current Liabilities |
461,416,378.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,375,234.05 |
| Deferred Income Tax Liabilities |
4,984,621.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,850,331.60 |
| Total Liabilities |
492,266,709.78 |
| Paid-In Capital(Or Share Stock) |
1,169,801,516.00 |
| Capital Surplus |
35,846,344.62 |
| Surplus Reserve |
193,164,555.07 |
| LESS:Treasury Stock |
31,890,970.09 |
| Undistributed Profits |
1,533,324,260.39 |
| Minority Stockholder's Interest |
233,022.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,914,806,776.29 |
| Owner's Equity（Stockholder's Equity） |
2,915,039,798.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,407,306,508.70 |
